• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tympanic Membrane and Ossicular-Sparing Modified Lateral Temporal Bone Resection.鼓膜及听骨链保留的改良颞骨外侧切除术
Otolaryngol Head Neck Surg. 2017 Sep;157(3):530-532. doi: 10.1177/0194599817712686. Epub 2017 Jun 13.
2
Squamous cell carcinoma involving the temporal bone: lateral temporal bone resection as primary intervention.涉及颞骨的鳞状细胞癌:作为主要干预手段的外侧颞骨切除术。
Otol Neurotol. 2013 Jan;34(1):141-50. doi: 10.1097/MAO.0b013e318278bf38.
3
Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies.颞骨外侧切除术治疗耳部及颞骨恶性肿瘤后的管理结果。
Otolaryngol Head Neck Surg. 2007 Dec;137(6):893-8. doi: 10.1016/j.otohns.2007.09.010.
4
Survival outcomes in surgical treatment of 72 cases of squamous cell carcinoma of the temporal bone.手术治疗 72 例颞骨鳞状细胞癌的生存结果。
Otol Neurotol. 2011 Jun;32(4):665-9. doi: 10.1097/MAO.0b013e318210b90f.
5
Evidence-based surgical management of T1 or T2 temporal bone malignancies.基于证据的 T1 或 T2 颞骨恶性肿瘤的外科治疗。
Laryngoscope. 2013 Jan;123(1):244-8. doi: 10.1002/lary.23637. Epub 2012 Sep 24.
6
Effect of Piecemeal vs En Bloc Approaches to the Lateral Temporal Bone on Survival Outcomes.分块与整块切除外侧颞骨对生存结局的影响。
Otolaryngol Head Neck Surg. 2018 Apr;158(4):716-720. doi: 10.1177/0194599818758994. Epub 2018 Feb 20.
7
Persistent otorrhoea with an abnormal tympanic membrane secondary to squamous cell carcinoma of the tympanic membrane.
J Laryngol Otol. 2011 Mar;125(3):318-20. doi: 10.1017/S0022215110002203. Epub 2010 Oct 29.
8
Squamous cell carcinoma of the temporal bone: results and management.颞骨鳞状细胞癌:结果与治疗
Otol Neurotol. 2008 Jun;29(4):549-52. doi: 10.1097/MAO.0b013e31816c7c71.
9
Operative findings of conductive hearing loss with intact tympanic membrane and normal temporal bone computed tomography.术中发现鼓膜完整、颞骨计算机断层扫描正常的传导性听力损失。
Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1409-14. doi: 10.1007/s00405-013-2585-y. Epub 2013 Jun 7.
10
[Squamous cell carcinoma of temporal bone: an analysis of long-term treatment results in 33 patients].[颞骨鳞状细胞癌:33例患者的长期治疗结果分析]
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1998 Oct;33(5):261-4.

引用本文的文献

1
Fat-augmented Temporal Fascia Flap for Defect Coverage following External Auditory Canal Cancer Resection.脂肪增强颞筋膜瓣用于外耳道癌切除术后缺损的覆盖
Plast Reconstr Surg Glob Open. 2024 May 20;12(5):e5839. doi: 10.1097/GOX.0000000000005839. eCollection 2024 May.
2
Treatment Strategies for Malignancies of the External Auditory Canal.外耳道恶性肿瘤的治疗策略
Curr Treat Options Oncol. 2022 Jan;23(1):43-53. doi: 10.1007/s11864-021-00931-3. Epub 2022 Feb 15.
3
[Clinical features and prognostic factors for early-stage external auditory canal carcinoma].[早期外耳道癌的临床特征及预后因素]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021 Oct;35(10):874-879. doi: 10.13201/j.issn.2096-7993.2021.10.003.
4
Squamous cell carcinoma of the temporal bone: A current review.颞骨鳞状细胞癌:当前综述
Laryngoscope Investig Otolaryngol. 2019 Nov 13;4(6):684-692. doi: 10.1002/lio2.330. eCollection 2019 Dec.

本文引用的文献

1
Surgical procedures for external auditory canal carcinoma and the preservation of postoperative hearing.外耳道癌的外科手术及术后听力保留
Case Rep Surg. 2012;2012:841372. doi: 10.1155/2012/841372. Epub 2012 Dec 1.
2
Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies.颞骨外侧切除术治疗耳部及颞骨恶性肿瘤后的管理结果。
Otolaryngol Head Neck Surg. 2007 Dec;137(6):893-8. doi: 10.1016/j.otohns.2007.09.010.
3
Analysis of 95 cases of squamous cell carcinoma of the external and middle ear.95例外耳道及中耳鳞状细胞癌分析。
Auris Nasus Larynx. 2006 Sep;33(3):251-7. doi: 10.1016/j.anl.2005.11.012. Epub 2006 Jan 20.
4
Lateral temporal bone resections.颞骨外侧切除术
Am J Surg. 1990 Oct;160(4):427-33. doi: 10.1016/s0002-9610(05)80559-8.

鼓膜及听骨链保留的改良颞骨外侧切除术

Tympanic Membrane and Ossicular-Sparing Modified Lateral Temporal Bone Resection.

作者信息

Ghavami Yaser, Haidar Yarah M, Maducdoc Marlon, Tjoa Tjoson, Moshtaghi Omid, Lin Harrison W, Djalilian Hamid R

机构信息

1 Division of Neurotology and Skull Base Surgery, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, Irvine, California, USA.

2 Division of Neurotology and Skull Base Surgery, Department of Biomedical Engineering, University of California, Irvine, Irvine, California, USA.

出版信息

Otolaryngol Head Neck Surg. 2017 Sep;157(3):530-532. doi: 10.1177/0194599817712686. Epub 2017 Jun 13.

DOI:10.1177/0194599817712686
PMID:28608748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6080309/
Abstract

A modified lateral temporal bone resection (mLTBR) is a unique technique that spares the tympanic membrane (TM) and ossicles in select patients with squamous cell carcinoma (SCCa). The records of 5 patients with SCCa of the temporal bone with negative frozen-section biopsy at the tympanic annulus were reviewed. The mean follow-up time for the patients was 29.2 months. One patient received postoperative radiation due to cervical nodal extracapsular spread. All patients were recurrence free as of the most recent follow-up (range, 8-50 months). Postoperative audiometry demonstrated an average conductive hearing loss of 9 dB (range, 0-17 dB). The mLTBR with sparing of the TM can be an effective alternative to the traditional lateral temporal bone resection (LTBR) with better hearing results for patients with SCCa involving the bony external auditory canal. In the short term, oncologic results of mLTBR appear equivalent to the LTBR. However, long-term follow-up is needed for >5-year outcomes.

摘要

改良外侧颞骨切除术(mLTBR)是一种独特的技术,可在部分鳞状细胞癌(SCCa)患者中保留鼓膜(TM)和听小骨。回顾了5例颞骨SCCa患者的记录,这些患者鼓膜环的冰冻切片活检结果为阴性。患者的平均随访时间为29.2个月。1例患者因颈部淋巴结包膜外扩散接受了术后放疗。截至最近一次随访(范围为8 - 50个月),所有患者均无复发。术后听力测试显示平均传导性听力损失为9 dB(范围为0 - 17 dB)。对于累及骨性外耳道的SCCa患者,保留TM的mLTBR可以是传统外侧颞骨切除术(LTBR)的有效替代方法,听力结果更好。短期内,mLTBR的肿瘤学结果似乎与LTBR相当。然而,需要进行超过5年的长期随访以观察结果。